{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/06/3288791/0/en/SCIENTURE-Announces-Third-Patent-Grant-for-ARBLI-losartan-potassium-Oral-Suspension-Strengthening-Long-Term-Market-Exclusivity-Through-2041.html", "message": "News view counter 706582 successfully enlarged"}